COVID-19 infection and vaccination and its relation to amyloidosis: what do we know currently?

WY Leung, HHL Wu, L Floyd, A Ponnusamy… - Vaccines, 2023 - mdpi.com
Amyloidosis is a complex disorder characterized by deposited insoluble fibrillar proteins
which misfold into β-pleated sheets. The pathogenesis of amyloidosis can vary but can be …

[HTML][HTML] Antibody response after initial vaccination for SARS-CoV-2 in patients with amyloidosis

E Kastritis, E Terpos, A Sklirou, F Theodorakakou… - …, 2021 - journals.lww.com
In systemic amyloidoses, misfolded proteins form amyloid fibrils that are deposited in various
tissues causing organ dysfunction. In systemic immunoglobulin light chain (AL) amyloidosis …

[HTML][HTML] COVID-19 exposure unmasking systemic amyloidosis with hepatic predominance

JR Russe-Russe, C Abramowitz, JR Pellegrini… - Cureus, 2022 - ncbi.nlm.nih.gov
Amyloidosis is characterized by depositing insoluble fibrillar proteins that misfold into beta-
pleated sheets. This phenomenon occurs on a systemic or local level and may interfere with …

Amyloidosis and COVID-19: experience from an amyloid program in Canada

E Lewis, N Fine, RJH Miller, C Hahn, S Chhibber… - Annals of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus (SARS-CoV2) and associated COVID-19
infection continue to impact patients globally. Patients with underlying health conditions are …

COVID-19 and Light Chain Amyloidosis: Correspondence

R Mungmunpuntipantip, V Wiwanitkit - The American Journal of …, 2022 - ncbi.nlm.nih.gov
We would like to discuss the article “COVID-19 and Light Chain Amyloidosis (AL), Adding
Insult to Injury,” 1 published in a recent issue of The American Journal of Medicine. Crees …

mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis

G Barzen, F Rieber, K Stangl, K Hahn, S Spethmann - Vaccine, 2024 - Elsevier
Introduction Amyloidosis is a rare disease in which malformed proteins are deposited in
tissues occurring mostly commonly in older age. These deposits can lead to severe organ …

COVID-19 and light chain amyloidosis, adding insult to injury

ZD Crees, K Stockerl-Goldstein - The American Journal of Medicine, 2022 - Elsevier
Light chain (AL) amyloidosis is a potentially fatal disease of monoclonal plasma cells that
leads to accumulation of light chain amyloid fibrils, organ damage, and the manifestations of …

Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis

R Bourguiba, A Terré, L Savey, E Oziol, T Hanslik… - Amyloid, 2024 - Taylor & Francis
Inflammatory (AA) amyloidosis is a rare type of amyloidosis that follows serum amyloid A
protein (SAA) deposition and occurs in patients with chronic systemic inflammation with …

Viruses and amyloids-a vicious liaison

P Hammarström, S Nyström - Prion, 2023 - Taylor & Francis
The crosstalk between viral infections, amyloid formation and neurodegeneration has been
discussed with varying intensity since the last century. Several viral proteins are known to be …

[HTML][HTML] Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis

N Liebers, SO Schönland, C Speer, D Edelmann… - …, 2022 - journals.lww.com
In the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
patients with hematologic diseases have an increased risk for severe disease courses. 1 …